Dividends policy
In the coming years, Nightingale Health will focus on funding its growth and developing its business. The company is committed to a very strict dividend policy that is connected to Nightingale Health’s result and financial standing. The company does not expect to distribute a dividend in the short or medium term.
Financial year 2022–2023
The Board of Director's proposal on the management of the result of the financial period
The parent company's distributable non-restricted equity on 30 June 2023 was EUR 80,784,991. The parent company's net loss for the financial period totaled EUR -16,816,398.
The Board of Directors proposes to the Annual General Meeting that no dividend be distributed for the financial year 1 July 2022-30 June 2023 and that the loss of the financial year is recorded in retained earnings.
Financial year 2021–2022
The Board of Director's proposal on the management of the result of the financial period
The parent company’s distributable non-restricted equity on 30 June 2022 was EUR 96,365,573. The parent company’s net loss for the financial period totaled EUR -14,438,586.
The Board of Directors proposes to the Annual General Meeting that no dividend be distributed for the financial year 1 July 2021–30 June 2022 and that the loss of the financial year is recorded in accumulated loss.
Financial year 2020–2021
The Board of Director's proposal on the management of the result of the financial period
The parent company’s distributable non-restricted equity on 30 June 2021 was EUR 122,586,544. The parent company’s net loss for the financial period totaled EUR -10,755,180.
The Board of Directors proposes to the Annual General Meeting that no dividend will be distributed for the financial year 1 July 2020 – 30 June 2021 and that the loss of the financial year is recorded in the retained earnings.